Putnam Investments’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
$915K Buy
244,684
+111,434
+84% +$417K ﹤0.01% 854
2023
Q3
$282K Buy
+133,250
New +$282K ﹤0.01% 1079